Skip to content

Surgical Simplex P Radeopaque Bone Cement

by Howmedica Corp.

PMA N17004

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA N17004

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberN17004 Date7 Oct 1971DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
BONE CEMENT
PMA Number
FDA Product Code
LOD
Device Class
Class II
Regulation
21 CFR Part 888.3027
Advisory Committee
Orthopedic
FDA Decision
APRL

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Simplex Radioopaque Bone Cement is a radiopaque orthopedic bone cement designed for use in orthopedic surgical procedures. It is formulated to provide mechanical stability and fixation in bone, particularly in joint replacements or fracture repairs, where radiopacity aids in postoperative imaging and assessment.

This device is supplied as a sterile, single-use product intended for intraoperative use in controlled surgical environments. It is classified as a Class II medical device under FDA regulations and has received Premarket Approval (PMA). The cement is packaged in sterile containers and must be handled under aseptic conditions to maintain sterility. No MRI safety information is specified, and sizes or additional handling instructions are not detailed in the provided data.

Other devices from Howmedica Corp.

See all devices from Howmedica Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Surgical Simplex Radioopaque Bone Cement in orthopedic procedures?

    The Surgical Simplex Radioopaque Bone Cement is specifically designed to provide mechanical stability and secure fixation in bone during orthopedic surgeries, such as joint replacements or fracture repairs. Its radiopacity allows for clear visualization on postoperative imaging, which aids in assessing the cement’s placement and integration with the bone.

  • Is this bone cement intended for reuse, or is it meant to be used only once per patient?

    This product is explicitly labeled as a sterile, single-use item, meaning it is intended for one-time intraoperative use only. Reuse is not recommended or supported by the manufacturer to maintain sterility and safety.

  • How should the Surgical Simplex Radioopaque Bone Cement be stored to ensure its integrity?

    The cement is supplied in sterile containers, so it must be stored in a way that preserves sterility—typically in a clean, dry environment away from direct sunlight or extreme temperatures. Since no specific storage instructions are provided beyond aseptic handling, adhering to standard sterile supply protocols (e.g., refrigeration if required by the manufacturer’s labeling) is advised.

  • What regulatory pathway was followed for approval of this bone cement, and what does that mean for its use?

    The Surgical Simplex Radioopaque Bone Cement received Premarket Approval (PMA) from the FDA, which is the highest level of regulatory clearance for medical devices. This approval indicates that the device has undergone rigorous clinical evaluation to demonstrate safety and effectiveness for its intended use in orthopedic procedures, ensuring it meets strict regulatory standards.